drugset / Trial / NCT00208819

A Comparison of Two Standard Therapies in the Management of Dementia With Agitation

NCT00208819

Phase 4 Completed 50 enrolled Emory University Abbott · collab
RandomizedParallel-groupOpen-labelTreatment

Summary

The purpose of this study is to determine whether an antipsychotic medication alone or an antipsychotic medication in combination with divalproex is the most effective and safest way to treat agitation in elderly patients with dementia.

Timeline

Start
2003-09
Primary completion
Completion
2007-07

Publications

  • Background Tune L. Management of Noncognitive Symptoms of Dementia. Essentials of Clinical Psychopharmacology, 2nd ed. 2001: 935-948.

Drugs

EvaluationDrugModalityDoseRoute
Subject Divalproex Sodium Small molecule
Subject Olanzapine Small molecule
Subject Quetiapine Small molecule
Subject Risperidone Other / unclassified

Indications